The objective of Imeglimin Research Council is to fostering development, innovation and guidance in the novel approach of T2DM Management.

Your shared experience, guidance and mentorship will be a bridge between Research and real world clinical Practice thereby improving the Quality of life in T2DM patient.

IRC also enables Clinician’s and students across Diabeto, Endo and other specialty to enhance their knowledge and expertise in managing T2DM with Novel drug like Imeglimin.

Imeglimin Research Council is committed to promoting Research, Innovation and Expertise of leading Clinicians like you.

This IRC platform is dedicated for the educative purpose only and Aurum Medcom dedicated to bring the excellence in novel approach in the management of T2DM. Aurum Medcom offers unique value based services in catering the need of Physicians, healthcare service providers and patients/consumers.